Author
Listed:
- Chen-Chi Liu
(Institute of Clinical Medicine, National Yang-Ming University)
- Shih-Pei Lin
(Institute of Clinical Medicine, National Yang-Ming University)
- Han-Shui Hsu
(Institute of Emergency and Critical Care Medicine, School of Medicine, National Yang-Ming University
Taipei Veterans General Hospital)
- Shung-Haur Yang
(Taipei Veterans General Hospital
School of Medicine, National Yang-Ming University)
- Chiu-Hua Lin
(Institute of Clinical Medicine, National Yang-Ming University)
- Muh-Hwa Yang
(Institute of Clinical Medicine, National Yang-Ming University
Taipei Veterans General Hospital)
- Mien-Chie Hung
(Graduate Institute of Cancer Biology, College of Medicine, Center for Molecular Medicine, China Medical University and Hospital
The University of Texas M.D. Anderson Cancer Center)
- Shih-Chieh Hung
(Institute of Clinical Medicine, National Yang-Ming University
Stem Cell Laboratory, Taipei Veterans General Hospital
Institute of Biomedical Sciences, Academia Sinica
Integrative Stem Cell Center, China Medical University Hospital)
Abstract
Targeting tumour-initiating cells (TICs) would lead to new therapies to cure cancer. We previously demonstrated that TICs have the capacity to survive under suspension conditions, while other cells undergo anoikis. Here we show that TICs exhibit increased phosphorylation levels of S727STAT3 because of PP2A inactivation. Collagen 17 gene expression is upregulated in a STAT3-dependent manner, which also stabilizes laminin 5 and engages cells to form hemidesmosome-like junctions in response. Blocking the PP2A-S727STAT3-collagen 17 pathway inhibits the suspension survival of TICs and their ability to form tumours in mice, while activation of the same pathway increases the suspension survival and tumour-initiation capacities of bulk cancer cells. The S727STAT3 phosphorylation levels correlate with collagen 17 expression in colon tumour samples, and correlate inversely with survival. Finally, this signalling axis enhances the ability of TIC to form tumours in mouse models of malignant lung cancer pleural effusion and spontaneous colon cancer metastasis.
Suggested Citation
Chen-Chi Liu & Shih-Pei Lin & Han-Shui Hsu & Shung-Haur Yang & Chiu-Hua Lin & Muh-Hwa Yang & Mien-Chie Hung & Shih-Chieh Hung, 2016.
"Suspension survival mediated by PP2A-STAT3-Col XVII determines tumour initiation and metastasis in cancer stem cells,"
Nature Communications, Nature, vol. 7(1), pages 1-19, September.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11798
DOI: 10.1038/ncomms11798
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11798. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.